Health Canada Grants Focal Healthcare Class II Medical Device License for Targeted Prostate Biopsy Device, Fusion Bx
TORONTO, ON – April 24, 2017 Focal Healthcare Inc. has been granted a Class II Health Canada Medical Device License for its targeted prostate biopsy device, Fusion Bx. Fusion Bx uses MRI/Ultrasound fusion to provide urologists with 3D image-guidance, allowing biopsies to be taken directly from suspicious cancer regions in the prostate for improved prostate […]